Gyre Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $31.4M | $29.1M |
| FY2016 | — | $16.1M | $10.3M |
| FY2017 | — | $30.8M | $14.5M |
| FY2018 | — | $119.9M | $31.2M |
| FY2019 | — | $68.3M | $15.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $31.4M | $29.1M |
| FY2016 | — | $16.1M | $10.3M |
| FY2017 | — | $30.8M | $14.5M |
| FY2018 | — | $119.9M | $31.2M |
| FY2019 | — | $68.3M | $15.4M |